Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific, including: Algernon, Biogen, Chugai, Cstone, Eisai, Gilead Sciences, Glenmark, Hua Medicine, Johnson & Johnson, Medicago, Merck, Shanghai Henlius, Transcenta.